DV
Dividend Vision

NUWE — Nuwellis Inc

Nuwellis Inc (NUWE)

Total return is -100.0% over the past 14.5 years, 734.5 points behind SPY at 634.5%. Its deepest 1-year drawdown was 99.4%.

Nuwellis Inc is a medical device company that develops, manufactures, and commercializes ultrafiltration therapy systems, including the Aquadex FlexFlow and Aquadex SmartFlow systems used to treat fluid overload in heart failure patients and other conditions. The company does not currently distribute dividends. Nuwellis appeals to investors seeking exposure to the medical device sector rather than those focused on generating dividend income.

NUWE key facts

Asset type
Stock
Asset class
Equity
Inception date
10/13/2017
Last close
$1.31
Market cap
$130,925
Average volume
289000.0
Payment date
10/19/2020
Beta
0.286
Payout ratio
0.0
P/E ratio
0.0314
Forward P/E
0.0
EPS
$45.20